Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

10/4/23 7:38:17 AM ET

Blank Checks

Finance

Get the next $BIOS alert in real time by email

Avertix Medical, Inc. ("Avertix" or the "Company"), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation (dba BioPlus Acquisition Corp.) ("BIOS") (NASDAQ:BIOS), a special purpose acquisition company, announced today that the two companies have mutually agreed to terminate their proposed business combination.

Get the next $BIOS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BIOS

Date	Price Target	Rating	Analyst

More analyst ratings

$BIOS
Press Releases

Fastest customizable press release news feed in the world

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. ("BIOS" or the "Company") (NASDAQ:BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have mutually agreed to terminate their previously announced business combination agreement and plan of reorganization (the "Business Combination Agreement"), effective as of October 4, 2023 and (ii) it intends to liquidate as soon as practicable after October 4, 2023 and to return funds to holders of its Class A ordinary shares that were included in the units issued in the Company's initial public offering ("Public Shares"). The Business Combination Agreement was dated as of May 2, 2023. The pa
10/4/23 7:30:00 AM ET
$BIOS
Blank Checks
Finance
Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. ("Avertix" or the "Company"), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation (dba BioPlus Acquisition Corp.) ("BIOS") (NASDAQ:BIOS), a special purpose acquisition company, announced today that the two companies have mutually agreed to terminate their proposed business combination. "While we were enthusiastic about the potential business combination with BIOS, we mutually agreed that the current market conditions are not co
10/4/23 7:30:00 AM ET
$BIOS
Blank Checks
Finance
Carbonhand is available for Veterans in the US
Bioservo signs a Sales Agent agreement with Trivet Medical LLC for sales of Carbonhand to Hospitals, Clinics, and Medical Centers within the Veterans Health Administration and Department of Defense in the US. With the first Sales Agent in place, the grip-strengthening device Carbonhand is available for all US Veterans suffering from impaired hand function. KISTA, Sweden, Aug. 29, 2023 /PRNewswire/ -- Trivet Medical LLC is a specialized strategic sales and distribution LLC, highly focused on commercializing disruptive, best-in-class med-tech devices and technologies. Founded by Charles Coyle, Trivet Medical's mission is to develop underrepresented and underserved healthcare conditions through
8/29/23 3:03:00 AM ET
$BIOS
Blank Checks
Finance

$BIOS
Market Insights

Live Market Insights

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
Avertix Medical, Inc. ("Avertix" or the "Company"), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation (dba BioPlus Acquisition Corp.) ("BIOS") (NASDAQ:BIOS), a special purpose acquisition company, announced today that the two companies have mutually agreed to terminate their proposed business combination.
10/4/23 7:38:17 AM ET
$BIOS
Blank Checks
Finance
Heart & Rhythm Institute Of Trinity And Avertix Announce Partnership To Improve Cardiac Care And Patient Monitoring
The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart & Rhythm Institute of Trinity, extending their commitment to redefining cardiac care in the Tampa, FL area Dr. Luis R. Annoni-Suau, MD, FACC and Dr. Carlos J. Bayron successfully performed the first two Guardian implants at the Heart and Rhythm Institute of Trinity
8/16/23 8:32:58 AM ET
$BIOS
Blank Checks
Finance
Avertix, Maker Of Only FDA-Approved Implantable Heart Attack Warning System, To Become Publicly Traded Via Merger With BIOS Acquisition Corporation
- Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian™ System, the first and only FDA-approved solution designed to detect and warn patients of cardiac events, including silent heart attacksEATONTOWN, N.J. and NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. ("Avertix" or the "Company"), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation (dba BioPlus Acquisition Corp.) ("BIOS") (NASDAQ:BIOS), a special purpose acquisition company, today announced that t
5/3/23 8:41:18 AM ET
$BIOS
Blank Checks
Finance

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

Chat with this insight

Recent Analyst Ratings for
$BIOS

$BIOS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

$BIOS
Financials

Live finance-specific insights

$BIOS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Purple Innovation Announces Cooperative Framework with Coliseum Capital

SEC Form 4 filed by Bioplus Sponsor Llc

$BIOS
SEC Filings

SEC Form 15-12G filed by BioPlus Acquisition Corp.

SEC Form 25-NSE filed by BioPlus Acquisition Corp.

SEC Form RW filed by BioPlus Acquisition Corp.

$BIOS
Press Releases

Fastest customizable press release news feed in the world

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate